e) Glycoprotein IIb/IIIa inhibitors and Low Molecular Weight Heparins

No

Current data do not support the use of IIb/IIIa agents in patients who meet thrombolytic criteria. In patients with acute coronary syndromes without ST elevations or changes for which thrombolytics are not indicated, studies are currently underway to address this combination, such as NICE-4.

Please select another answer.